BRIEF published on 03/25/2026 at 15:16, 4 months 20 days ago NANOBIOTIX Responds to Media Speculation on Takeover Intentions Biotechnology Nanotechnology Takeover Speculation NANOBIOTIX Public Statement
PRESS RELEASE published on 03/25/2026 at 15:11, 4 months 20 days ago Declaration de NANOBIOTIX concernant une recente rumeur mediatique Nanobiotix publie une déclaration officielle concernant une rumeur de prise de contrôle. Aucun processus en cours. La société réaffirme son engagement envers l'innovation dans le domaine de la biotechnologie Innovation Déclaration Biotechnologie NANOBIOTIX Rumeur
PRESS RELEASE published on 03/25/2026 at 15:11, 4 months 20 days ago NANOBIOTIX Statement Regarding Recent Media Speculation Nanobiotix issues statement addressing media speculation on public take-over intentions, denying any such plans and highlighting factual inaccuracies in recent reports Media Speculation Statement NANOBIOTIX Public Take-over Factual Inaccuracies
BRIEF published on 03/12/2026 at 21:20, 5 months 2 days ago Nanobiotix annonce les détails relatifs aux droits de vote et au capital social Euronext Paris Capital Social Nasdaq Droit De Vote NANOBIOTIX
BRIEF published on 03/12/2026 at 21:20, 5 months 2 days ago Nanobiotix Announces Voting Rights and Share Capital Details Euronext Paris Share Capital Voting Rights Nasdaq NANOBIOTIX
PRESS RELEASE published on 03/12/2026 at 21:15, 5 months 2 days ago Voting Rights and Shares Capital of the Company Nanobiotix discloses voting rights and shares capital details as of February 28, 2026, on Euronext Paris and Nasdaq markets. Learn about their disruptive therapeutic approaches and global presence Euronext Paris Voting Rights Nasdaq Shares Capital NANOBIOTIX
BRIEF published on 02/25/2026 at 22:20, 5 months 17 days ago NANOBIOTIX Présente à des Conférences Clés en Mars Biotechnologie Conférences Investisseurs NANOBIOTIX Avancées Cliniques Traitements Cancer
BRIEF published on 02/25/2026 at 22:20, 5 months 17 days ago NANOBIOTIX Presents at Key Conferences in March Biotechnology Investor Conferences Cancer Treatments NANOBIOTIX Clinical Advances
PRESS RELEASE published on 02/25/2026 at 22:15, 5 months 17 days ago NANOBIOTIX participera à plusieurs conférences investisseurs en mars Nanobiotix participera à plusieurs conférences investisseurs en mars. Détails sur les événements et les participants. La société présentera ses approches novatrices en biotechnologie Biotechnologie Cancer Conférences Investisseurs NANOBIOTIX Approches Therapeutiques
BRIEF published on 02/17/2026 at 22:20, 5 months 25 days ago Nanobiotix annonce une mise à jour de ses droits de vote et de son capital social Euronext Paris Capital Social Droit De Vote Divulgation Financière NANOBIOTIX
Published on 08/15/2026 at 00:50, 13 hours 52 minutes ago Revive Therapeutics Reports Grant of Options
Published on 08/15/2026 at 00:15, 14 hours 27 minutes ago Full Circle Lithium Announces Closing of Private Placement
Published on 08/14/2026 at 23:45, 14 hours 57 minutes ago AI/ML Innovations Inc. Announces Proposed Private Placement
Published on 08/14/2026 at 23:25, 15 hours 17 minutes ago NuRAN Wireless Closes $7.6 Million Financing
Published on 08/14/2026 at 23:00, 15 hours 42 minutes ago Medicure Reports Financial Results for Quarter Ended June 30, 2026 and Schedules August 17, 2026 Conference Call
Published on 08/15/2026 at 08:05, 6 hours 37 minutes ago SKYWORTH Solar to Launch SolaMate Balcony Solar System on Joybuy Germany on August 15
Published on 08/14/2026 at 18:15, 20 hours 27 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/14/2026 at 16:05, 22 hours 37 minutes ago GATORADE WELCOMES AITANA BONMATÍ TO TEAM GATORADE AHEAD OF THE NEW FOOTBALL SEASON
Published on 08/13/2026 at 18:00, 1 day 20 hours ago Chiffre d’affaires du 1er trimestre 2026-27 : 14,4 M€
Published on 08/11/2026 at 17:45, 3 days 20 hours ago DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 3 days 21 hours ago Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 4 days 20 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 4 days 20 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
